Irodalomjegyzék
1. Rostami-Nejad M, Rostami K, Sanaei M, et al.: Rotavirus and coeliac autoimmunity
among adults with non-specific gastrointestinal symptoms. Saudi Med J. 2010
Aug;30(8):891-4.
2. Tursi A, Elisei W, Giorgetti GM, et al.: Prevalence of celiac disease and symptoms in
relatives of patients with celiac disease. Eur Rev Med Pharmacol Sci. 2010
Jun;14(6):567-72.
3. Catassi C, Fasano A: Celiac disease diagnosis: simple rules are better than
complicated algorithms. Am J Med. 2010 Aug;123(8):691-3.
4. Korkut E, Bektas M, Oztas E, et al.: The prevalence of celiac disease in patients
fulfilling Rome III criteria for irritable bowel syndrome. Eur J Intern Med. 2010
Oct;21(5):389-92.
5. Caccamo D, Currò M, Ientile R: Expert Opin Ther Targets. 2010 Sep;14(9):989-1003.
Potential of transglutaminase 2 as a therapeutic target.
6. Tjon JM, van Bergen J, Koning F: Celiac disease: how complicated can it get?
Immunogenetics. 2010 Oct;62(10):641-51.
7. Wu J, Xia B, von Blomberg BM, et al.: Coeliac disease in China, a field waiting for
exploration. Rev Esp Enferm Dig. 2010 Jul;102(8):472-7.
8. Sugai E, Moreno ML, Hwang HJ, et al.: Celiac disease serology in patients with
different pretest probabilities: is biopsy avoidable? World J Gastroenterol. 2010 Jul
7;16(25):3144-52.
9. Moccia M, Pellecchia MT, Erro R, et al.: Restless legs syndrome is a common feature
of adult celiac disease. Mov Disord. 2010 May 15;25(7):877-81.
10. Evans KE, Leeds JS, Morley S, et al.: Pancreatic insufficiency in adult celiac disease:
do patients require long-term enzyme supplementation? Dig Dis Sci. 2010
Oct;55(10):2999-3004.
11. Ravelli A, Villanacci V, Monfredini C, et al.: How patchy is patchy villous atrophy?:
distribution pattern of histological lesions in the duodenum of children with celiac
disease. Am J Gastroenterol. 2010 Sep;105(9):2103-10.
12. Cheung DY, Lee IS, Chang DK, et al.: Korean Gut Images Study Group. Capsule
endoscopy in small bowel tumors: a multicenter Korean study. J Gastroenterol
Hepatol. 2010 Jun;25(6):1079-86.
13. Kondo J, Iijima H, Abe T, et al.: Roles of double-balloon endoscopy in the diagnosis
and treatment of Crohn’s disease: a multicenter experience. J Gastroenterol. 2010
Jul;45(7):713-20.
14. Grève E, Moussata D, Gaudin JL, et al.: High diagnostic and clinical impact of smallbowel capsule endoscopy in patients with hereditary hemorrhagic telangiectasia with
overt digestive bleeding and/or severe anemia. Gastrointest Endosc. 2010
Apr;71(4):760-7.
15. May A, Färber M, Aschmoneit I, et al.: Prospective multicenter trial comparing pushand-pull enteroscopy with the single- and double-balloon techniques in patients with
small-bowel disorders. Am J Gastroenterol. 2010 Mar;105(3):575-81.
16. Liao Z, Xu C, Li ZS: Completion rate and diagnostic yield of small-bowel capsule
endoscopy: 1 vs. 2 frames per second. Endoscopy. 2010 May;42(5):360-4.
17. Liu HY, Pi XT, Zheng XL, et al.: Pharmacokinetics of aminophylline delivered to the
small intestine and colonusing remote controlled capsules. Chin Med J (Engl). 2010
Feb 5;123(3):320-5.
18. Niemenmaa H, Mäkelä T, Jussila A, et al.: The diagnostic value of video capsule
endoscopy.Eur J Intern Med. 2010 Oct;21(5):383-5.
19. Halfdanarson TR, McWilliams RR, Donohue JH et al.: A single-institution experince
with 491 cases of small bowel adenocarcinoma. Am J Surg Pathol 2010;199:797-803.
20. Chang HK, Yu E, Kim J et al.: Adenocarcinoma of the small intestine: a multiinstitutional study of 197 surgically resected cases. Hum Path 2010;41:1087-1096.
21. AJCC Cancer Staging Handbook Seventh Edition. 2010. ISBN 978-0-387-88442-4.
22. Wu, Xu, Yin, Qu: Usefulness of CT angiography in diagnosing acute gastrointestinal
bleeding: A meta-analysis. World J Gastroenterol 2010 August 21;16 (31): 3957-3963.
23. Gold JS, Gönen M, Gutiérrez A, et al.: Development and validation of a prognostic
nomogram for recurrence-free survival after complete surgical resection of localised
primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol. 2009
Nov;10(11):1045-1052. Epub 2009 Sep 28.
24. Târcoveanu E, Dimofte G, Vasilescu A, et al.: Laparoscopic management of
gastrointestinal stromal tumours. Acta Chir Belg. 2010 May-Jun;110(3):295-302.
25. Chung JC, Chu CW, Cho GS, et al.: Management and outcome of gastrointestinal
stromal tumors of the duodenum. J Gastrointest Surg. 2010 May;14(5):880-883.
26. Speranza G, Doroshow JH, Kummar S: Adenocarcinoma of the small bowel: changes
in the landscape? Curr Opin Oncol. 2010 Jul;22(4):387-393.
27. Rex DK. Update on colonoscopic imaging ang projections for the future. Clin
Gastroenterol Hepatol 2010;8:318-321.
28. Gaglia A, Papanikolaou IS, Veltzke-Schlieker W. New endoscopy devices to improve
population adherence to colorectal cancer prevention programs. World J Gastrointest
Endosc. 2010; 16:244-51.
29. Striegel J, Jakobs R, Van Dam J. Determining scope position during colonoscopy
without use of ionizing radiation or magnetic imaging: the enhanced mapping ability
of the NeoGuide Endoscopy System. Surg Endos 2010 Aug 21.
30. Waye JD. Improving lesion detection during colonoscopy. Gastroenterol Hepatol.
2010; 6:647-52.
31. Waye JD, Height RI, Fleischer DE et al.: A retrograde-viewing device improves
detection of adenomas int he colon: a prospective efficacy evaluation. Gastrointest
Endosc. 2010;71:551-556.
32. DeMarco DC, Odstrcil E, Lara LF et al.: Impact of experience with retrogradeviewing device on adenoma detection rates and withdrawal times during endoscopy:
the Third Eye Retroscope study group. Gastrointest Endosc. 2010:71:542-550
33. Horiuchi A, Nakayama Y, Kato N et al.: Hood assisted colonoscopy is more effective
in detection of colorectal adenomas than narrow-band imaging. Clin Gastroenterol
Hepatol 2010;8:379-83.
34. Buchner A, Shahid MW, Heckman MG et al.: High definition colonoscopy detects
colorectal polyps et a higher rate than standard white light colonoscopy. Clin
Gastroenterol Hepatol 2010;8:364-70.
35. Gross S, Buchner A, Cangerni J ez al.: Prospective randomized back-to-back trial
comparing narrow band imaging to conventional colonoscopy for adenoma detection.
Gastroenterol 2008;134:A47-A48
36. Hoffman A, Sar F, Goetz M et al.: High definition colonoscopy combined with i-Scan
is superior in the detection of colorectal neoplasias compared with standard video
colonoscopy: a prospective randomized controlled trial Endoscopy 2010; 42:866-9
37. Dekker E, Eas JE. Does advanced endoscopic imaging increase the efficacy of
surveillanse colonoscopy, Endoscopy. 2010;42:866-9.
38. De Wijkerslooth TR, Dekker E. Colon tumors and colonoscopy. Endoscopy
2010;42:934-7.
39. Atkin WS, Cuzick J, Duffy SW et al.: UK flexible sigmoidoscopy screening trial:
colorectal cancer incidence and mortality rates et 11 years after single screening
xeamination. Gastroenterol 2010;138:S53
40. Tang RS, Savides TJ, Muthusamy VR et al.: Quality of colonoscopy withdrawal
technique and variability in adenoma detection rates: is technica more impontant than
tima? Gastrointest Endosc 2010; 71: AB116
41. Leung JW, Toomsen I, Mann SK et al.: Chromoendoscopy (Indigo Carmine) combined
with warm water infusion in lieu of air sufflation (water method) during insertion
enhanced adenoma detection in screening and survaillance colonoscopy. Gastrointest
Endosc 2010;71:AB107
42. Kuiper T, Van Den Broek FJ, Naber AH et al.: Endoscopic tri-modal imaging (ETMI)
for the detection and classification of aerly colorectal neoplasia: a multicenter
randomized controlled trial. Gastrointest Endosc 2010;71:AB142.
43. Gheonea DI, Saftoiu A, Ciurea T, et al.: Confocal laser endomicroscopy of the colon.
J Gastrointestin Liver Dis. 2010;19:207-11.
44. Neumann H, Kiesslich R, Wallace MB, et al.: Confocal laser endomicroscopy:
technical advances and clinical applications. Gastroenterology. 2010;139:388-92,
392.e1-2.
45. Sanduleanu S, Driessen A, Gomez-Garcia E, et al.: In vivo diagnosis and
classification of colorectal neoplasia by chromoendoscopy-guided confocal laser
endomicroscopy. Clin Gastreoenterol Hepatol 2010;8:371-78.
46. Moussata D, Goetz M, Kiesslich R. Confocal laser endomicroscopy is a new imaging
modality for recognition of intramucosal bacteria in inflammatory bowel disease in
vivo. Gut. 2010; 60:26-33.
47. Dumonceau JM, Riphaus A, …Racz I et al.: European Society of Gastrointestinal
Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and
Associates, and the European Society of Anaesthesiology Guideline: Nonanesthesiologist administration of propofol for GI endoscopy. Endoscopy.
2010;42:960-74.
48. Sporea I, Popescu A, Sandesc D, et al.: Colonoscopy and sedation in Romania: early
experience using a balanced propofol regimen. J Gastrointestin Liver Dis. 2010;
19:27-30.
49. Leung FW, Aljebreen AM, Brocchi E et al.: Sedation-risk-free colonoscopy for
minimizing the burden of colorectal cancer screening. World J Gastrointest Endosc.
2010;2:81-9.
50. Moshkowitz M, Hirsch Y, Carmel I, et al.: A novel device for rapid cleaning of poorly
prepared colons. Endoscopy. 2010;42:834-6.
51. C.W. Leung, T. Kaltenbach, R. Soetikno, et al.: Water immersion versus standard
colonoscopy insertion tecnique: randomized trial shows promise for inimal sedation.
Endoscopy 2010;42: 557-563
52. Wilson J, Hair C, Knight R, et al.: High incidence of inflammatory bowel disease in
Australia: a prospective population-based Australian incidence study. Inflamm Bowel
Dis 2010;16:1550–1556
53. Kaplan GG, Hubbard J, Korzenik J, et al.: The inflammatory bowel diseases and
ambient air pollution: a novel association. Am J Gastroenterol 2010:105:2412-2419.
54. Halfvarson J. Genetics in twins with Crohn’s disease: less pronounced than previously
believed? Inflamm Bowel Dis 2010;17:6-12.
55. Thia K, Faubion WA, Loftus EV Jr, et al. Short CDAI: development and validation of
a shortened and simplified Crohn’s disease activity index. Inflamm Bowel Dis
2011;17:105-111.
56. van der Heide F, Dijkstra A, Albersnagel FA, et al.: Active and passive smoking
behaviour and cessation plans of patients with Crohn’s disease and ulcerative colitis.
JCC 2010;4:125-131.
57. Schoepfer M, Beglinger C, Straumann A, et al.: Fecal calprotectin correlates more
closely with the simple endoscopic score for Crohn ’s disease (SES-CD) than CRP,
blood leukocytes, and the CDAI. Am J Gastroenterol 2010;105:162-169.
58. Garcia-Sánchez V, Iglesias-Flores E, González R, et al.: Does fecal calprotectin
predict relapse in patients with Crohn’s disease and ulcerative colitis? JCC
2010;4:144-152.
59. Oussalah A, Lauerent V, Brout O, et al.: Additional benefit of procalcitonin to Creactive protein to assess disease activity and severity in Crohn’s disease. Aliment
Parmacol Ther 2010;32:1135-1144.
60. Regueiro M, Kip KE, Schraut W, et al.: Crohn’s disease activity index does not
correlate with endoscopic recurrence one year after ileocolonic resection. Infl Bowel
Dis 2010;17:118-126.
61. Koilakou S, Sailer J, Peloschek P, et al.: Endoscopy and MR enteroclysis: equivalent
tools in predicting clinical recurrence in patients with Crohn’s disease after ileocolonic
resection. Inflamm Bowel Dis 2010;16:198-213.
62. Peyrin-Biroulet L, Loftus EV Jr,Colombel JF, et al.: The natural history of adult
Crohn’s disease in population-based cohorts. Am J Gastroenterol 2010;105:289-297.
63. Thia K, Sandborn WJ, Harmsen WS, et al.: Risk factors associated with progression to
intestinal complicatrions of Crohn’s disease in a population-based cohort.
Gastroenterology 2010;139:1147-1155.
64. Schaefer ME, Machan JT, Kawatu D, et al.: Factors that determine risk for surgery in
pediatric patients with Crohn’s disease. Clin Gatoenterol Hepatol 2010;8:789-794.
65. Pigneur B, Seksik P, Viola S, et al.: Natural history of Crohn-s disease: comparison
between childhood- and adult-onset disease. Inflamm Bowel Dis 20010;16:953-961.
66. Lakatos PL, David G, Pandur T, Lakatos L, et al.: IBD in the elderly populatios:
results from a population-based study in Western Hungary, 1977-2008. JCC 2010;4:
67. Duricova D, Pedersen N, Elkjaer M, et al.: Overall and cause-specific mortality in
Crohn’s disease: a meta-analitis of population-based studies. Inflamm Bowel Dis
2010;16:347-353.
68. Lakatos PL. Prediction of disease course in IBD World J Gastroenterol 2010;16:2589-
2590.
69. Lakatos PL, Kiss LS. Is the disease course predictable in inflammatory bowel disease?
World J Gastroenterol 2010,16:2591-2599.
70. Louis E, Belaiche J, Reenaers C. Do clinical factors help to predict disease course in
IBD? WJG 2010;16:2600-2603.
71. Dubinsky MC. Serologic and laboratory markers in prediction of the disease course in
IBD. WJG 2010;16:2604-2608.
72. Scaldaferri F, Correale C, Gasbarrini A, Danese S. Mucosal biomarkers in IBD? Key
pathogenetic players of disease predictors? WJG 2010;16:2616-2625.
73. Vermiere S. Role of genetics in prediction of disease course and response to therapy.
WJG 2010;16:2609-2615.
74. Allez M, Lémann M. Role of endoscopy in predicting the disease course in IBD. WJG
2010;16:2626-2632.
75. Voegtlin M, Vavricka SR, Schoepfer AM, et al.: Prevalence of anaemia in
inflammatory bowel disease in Switzerland: A cross-sectional study in patients from
private practices and university hospitals. JCC;4:642-648.
76. Novacek G, Weltermann A, Sobala A, et al.: Inflammatory bowel disease is a risk
factor for recurrent venous thromboembolism. Gastroenterology 2010;139:779-787.
77. van der Woude, Kolacek S, Dotan I, et al.: European evidence-based consensus on
reproduction in inflammatory bowel disease. JCC 2010;4:493-510.
78. Pedersen N, Duricova D, Elkjaer M, et al.: Risk of extraintestinal cancer in
inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J
Gastroenterol 2010;1480-148.
79. Hou JK, Velayos F, Terrault N, et al.: Viral hepatitis and inflammatory bowel disease.
Inflamm Bowel Dis 2010;16:925-932.
80. Jackson CA, Clatworthy J, Robinson A, et al.: Factors associated with non-adherence
to oral medication for inflammatory bowel disease. Am J Gastroenterol 2010;105:525-
539.
81. Lakatos PL, Czegledi Z, David G, Lakatos L, et al.: Association of adherence to
therapy and complementary and alternative medicine use with demograpgic factors
and disease phenotype in patients with inflammatory bowel disease. JCC 2010;4:283-
290.
82. Hausmann J, Zabel K, Herrmann E, et al.: Methotrexate for maintenance of remission
in chronic active Crohn’s disease: long-term single-center experience and metaanalysis of observational studies. Inflamm Bowel Dis 2010,16:1195-1202.
83. Ramadas AV, Gunesh S, Thomas GAO, et al.: Natural history of Crohn’s disease in a
population-based cohort from Cardiff (1986-2003): a study of changes in medical
treatment and surgical resection rates. Gut 2010;59:1200-1206.
84. Smith MA, Irving PM, Marinaki AM, et al.: Review article: malignancy on thriopurine
treatment with special reference to inflammatory bowel disease. Aliment Pharmacol
Ther 2010;32:119-130.
85. Armstrong RG, West J, Card T. Risk of cancer in inflammatory bowel disease treated
with azathioprine: a UK population-based case-control study. Am J Gastroenterol
2010;105:1604-1609.
86. Beaugerie CJ, Colombel JF, Hébuterne X, et al.: Pregnancy outcome in patients with
inflammatory bowel disease treated with thiopurines: cohort from the CESAE study.
Gut 2010:nov.29. Epub ehead of print.
87. Doherty GA, Bennett GC, Cheifetz AS, et al.: Meta-analysis: targeting the intestinal
microbiota in prophylaxis for post-operative Crohn’s disease. Aliment Pharmacol
Ther 2010;31:802–809
88. Govani SM, Higgins PDR. Combination of thiopurines and allopurinol: Adverse
events and clinical benefit in IBD. JCC;4:444-449.
89. Papay. The impact of thiopurines on the risk of surgical recurrence in patients with
Crohn’s disease after first intestinal surgery. Am J Gastroenterol 2010;105:1158-1164.
90. Colombel JF, Sandborn WJ, Reinisch W, et al.: Infliximab, azathioprine, or
combination therapy for Crohn’s disease. NEJM 2010;362:1383-1395.
91. Bultman E, Kuipers EJ, van der Woude CJ. Systematic review: steroid withdrawal in
anti-TNF treated patients with inflammatory bowel disease. Aliment Pharmacol Ther
2010;32:313-323.
92. Sorentino D, Paviotti A, Terrosu G, e al.: Law-dose maintenance therapy with
infliximab prevents postsurgical recurrence of Crohn’s disease. Clin Gastroenterol
Hepatol 2010;8:591-599.
93. Baert F, Glorieus E, D’Haens G,et al.: Adalimumab response dose escalation and
dose de-escalation success rate in a large national cohort of Crohn’s patients. Gut
2010;59SIII)A186. UEGW Barcelona
94. Echarri A, Gallego JC, Ollero V, et al .: Adalimumab treatment for inflammatory
Crohn’s disease strictures. Gut 2010;59SIII):A192. UEGW Barcelona
95. Billioud V, Laharie D, Filippi J, et al.: Adherence to adalimumab therapy in Crohn’s
disease: a French multicentre experience. Gut 2010;59(SIII):A409 UEGW Barcelona
96. Allez M, Vermeire S, Mozziconacci N, et al.: The fficacy and safety of a third antiTNF monoclonal antibody in Crohn’s disease after failure of two othzer anti TNF
antibodies. Aliment Pharmacol Ther 2010;31:92-101.
97. Grimaud JC, Munoz-Bongrad N, Sirpoudhis L, et al.: Fibrin glue is effective healing
perianal fistulas in patients with Crohn’s disease. Gastroenterology 2010;138:2275–
2281
98. Yang Z, Wu Q, Wu K, et al.: Meta-analysis: pre-operative infliximab treatment and
short-term post-operative complications in patients with ulcerative colitis. Aliment
PharmacolTher 2010;31:486-492.
99. Zanaba Y, Doménech E, Maňosa M, et al.: Infliximab safety profile and long-term
applicability in inflammatory bowel disease: 9-year experience in clinical practice.
Aliment Pharmacol Ther 2010;31.553-560.
100. Thai A, Prindville T. Hepatosplenic T-cell lymphoma and inflammatory bowel
disease. JCC 2010;4:511-522.
101. Doherty GA, Bennett GC, Cheifetz AS, et al.: Meta-analysis: targeting the
intestinal microbiota in prophylaxis for post-operative Crohn’s disease. Aliment
Pharmacol Ther 2010;31:802-809.
102. Mueller T, Rieder B, Bechtner G, et al.: The response of Crohn’s strictures to
balloon dilation. Aliment Pharmacol Ther 2010;31:634-639.
103. Iesalnieks I, Kilger A, Glass H et al.: Perforating Crohn’s ileitis: delay of
surgery is associated with inferior postoperative outcome. Inflamm Bowel Dis 2010
16:2125-2130.
104. Shen B, Patel S, Lian L. Natural history of Crohn’s disease in patients who
underwent intentional restorative proctocolectomy with ileal pouch-anal anastomosis.
Aliment Pharmacol Ther 2010;31:741-753.
105. Langille M, Bernard A, Rodgers C et al. Systematic review of the qulity of
patient information ont he internet regarding inflammatory bowel disease treatments.
Clin Gastroenterol Hepatol 2010;8:322-328.
106. Kinugasa T, Akagi Y, Yoshida T et al.: Increased claudin-1 protein expression
contributes to tumorigenesis in ulcerative colitis-associated colorectal cancer.
Anticancer Res 2010;30:3181-3186.
107. Denoya P, Canedo J, Berho M et al.: Granulomas in Crohn’s disease: Does
progression through bowel layers affect presentation or predict recurrence? Colorectal
Dis 2010 Sep 22. [Epub ahead of print]
108. Ince AT, Günes P, Senates E et al.: Can an immunohistochemistry method
differentiate intestinal tuberculosis from Crohn’s disease in biopsy specimens? Dig
Dis Sci 2010, Sep 8. [Epub ahead of print]
109. Allen, Baker, Einstein et al.: Effect of Altering Automatic Exposure Control
Settings and Quality Reference mAs on Radiation Dose, Image Quality, and
Diagnostic Efficacy in MDCT Enterography of Active Inflammatory Crohn’s Disease
AJR 2010; 195: 89–1002.
110. Migaleddu, Ouaia, Scanu et al.: Inflammatory activity in Crohn’s disease: CEUSAbdom Imaging 2010.may 13
111. Pallotta, Giovannone, Pezzotti et al.: Ultrasonographic detection and
assessment of the severity of Crohn’s disease recurrence after ileal resection BMC
Gastroenterology 2010, 10: 69
112. Chen, Lee, Kwong et al.: Cerebral White Matter Lesions in Patients with
Crohn’s Disease. J Neuroimaging 2010 Nov 17. doi: 10.1111/j.1552-
6569.2010.00538.x. [Epub ahead of print]
113. Shyn PB, Mortele KJ, Britz-Cunningham SH et al.: Low-dose 18F-FDG
PET/CT enterography: improving on CT enterography assessment of patients with
Crohn disease. J Nucl Med. 2010 Dec;51(12):1841-8.
114. Groshar D, Bernstine H, Stern D et al.: PET/CT enterography in Crohn
disease: correlation of disease activity on CT enterography with 18F-FDG uptake. J
Nucl Med. 2010 Jul;51(7):1009-14. Epub 2010 Jun 16.
115. Mota, Coelho, Simal et al.: Leukocyte-technetium-99m uptake in Crohn’s
disease: Does it show subclinical disease? World J Gastroenterol 2010 January 21;
16(3): 365-371
116. Feuerbach S. MRI enterography: the future of small bowel diagnostics? Dig
Dis. 2010;28(3):433-8
117. Kayhan, Oommen, Dahi, et al.: Magnetic resonance enterography in Crohn’s
disease: Standard and advanced techniques. World J Radiol 2010 April 28; 2(4): 113-
121
118. Bruining. CT enterography: is it the current state-of-the-art for small bowel
diagnostics? Dig Dis. 2010;28(3):429-32
119. Schmidt S, Guibal A, Meuwly JY et al.: Acute complications of Crohn’s
disease: comparison of multidetector-row computed tomographic enterography with
magnetic resonance enterography. Digestion. 2010;82(4):229-38
120. Fiorino G, Bonifacio C, Peyrin-Birouletet al.: Prospective comparison of
computed tomography enterography and magnetic resonance enterography for
assessment of disease activity and complications in ileocolonic Crohn’s disease.
Inflamm Bowel Dis. 2010 Nov 8
121. Minordi LM, Vecchioli A, Mirk P et al.: CT 19enterography with polyethylene
glycol solution vs CT enteroclysis in small bowel disease. Br J Radiol. 2010 Oct[Epub
ahead of print]
122. Cappabianca S, Granata V, Di Grezia G et al.: The role of nasoenteric
intubation in the MR study of patients with Crohn’s disease: our experience and
literature review. Radiol Med. 2010 Oct 27. [Epub ahead of print]
123. Gallego JC, Echarri AI, Porta. Ileal Crohn’s disease: MRI with endoscopic
correlation. Eur J Radiol. 2010 Jun 24. [Epub ahead of print]
124. Zappa M, Stefanescu C, Cazals-Hatem D et al.: Which magnetic resonance
imaging findings accurately evaluate inflammation in small bowel Crohn’s disease? A
retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis. 2010
Aug 18.
125. Oussalah A, Laurent V, Bruot O et al.: Diffusion-weighted magnetic resonance
without bowel preparation for detecting colonic inflammation in inflammatory bowel
disease. Gut 2010 Aug; 59(8):1056-65.
126. Ananthakrishnan AN, McGinley EL, Binion DG, et al.: A Nationwide Analysis
of Changes in Severity and Outcomes of Inflammatory Bowel Disease
Hospitalizations. J Gastrointest Surg. 2010 Nov 25. Epub ahead of print.
127. Iesalnieks I, Kilger A, Glaß H, et al.: Perforating Crohn’s ileitis: Delay of
surgery is associated with inferior postoperative outcome. Inflamm Bowel Dis. 2010
Dec;16(12):2125-2130. doi: 10.1002/ibd.21303.
128. Pedersen N, Duricova D, Lenicek M, et al.: Infliximab dependency is related to
decreased surgical rates in adult Crohn’s disease patients. Eur J Gastroenterol Hepatol.
2010 Oct;22(10):1196-203.
129. Slattery E, Keegan D, Hyland J, et al.: Surgery, Crohn’s Disease, and the
Biological Era: Has There Been an Impact? J Clin Gastroenterol. 2010 Dec 3. Epub
ahead of print.
130. Jones DW, Finlayson SR. Trends in surgery for Crohn’s disease in the era of
infliximab. Ann Surg. 2010 Aug;252(2):307-12.
131. Holubar SD, Dozois EJ, Privitera A, et al.: Minimally invasive colectomy for
Crohn’s colitis: a single institution experience. Inflamm Bowel Dis. 2010
Nov;16(11):1940-6.
132. Nasir BS, Dozois EJ, Cima RR, et al.: Perioperative anti-tumor necrosis factor
therapy does not increase the rate of early postoperative complications in Crohn’s
disease. J Gastrointest Surg. 2010 Dec;14(12):1859-66. Epub 2010 Sep 25.
133. Canedo J, Lee SH, Pinto R, et al.: Surgical resection in Crohn’s disease: is
immunosuppressive medication associated with higher postoperative infection rates?
Colorectal Dis. 2010 Oct 22. doi: 10.1111/j.1463-1318.2010.02469.x. [Epub ahead of
print]
134. Gapasin J, Van Langenberg DR, Holtmann G, et al.: Potentially avoidable
surgery in IBD: What proportion of patients come to resection without optimal
preoperative therapy? A guidelines-based audit. Intern Med J. 2010 Jul 30. [Epub
ahead of print]
135. McLeod RS, Wolff BG, Ross S, et al.: Investigators of the CAST Trial.
Recurrence of Crohn’s disease after ileocolic resection is not affected by anastomotic
type: results of a multicenter, randomized, controlled trial. Dis Colon Rectum. 2009
May;52(5):919-27.
136. Tonelli F, Fazi M, Di Martino C. Ileocecal strictureplasty for Crohn’s disease:
long-term results and comparison with ileocecal resection. World J Surg. 2010
Dec;34(12):2860-6.
137. Hotokezaka M, Ikeda T, Uchiyama S, et al.: Side-to-side-to-end strictureplasty
for Crohn’s disease. Dis Colon Rectum. 2009 Nov;52(11):1882-6.
138. Kawahara H, Watanabe K, Ushigome T, et al.: Where is the best skin incision
for partial resection of the small intestine? Hepatogastroenterology. 2010 JulAug;57(101):794-6.
139. Alessandroni L, Bertolini R, Campanelli A, et al.: Video-assisted versus open
ileocolic resection in primary Crohn’s disease: a comparative case-matched study.
Updates Surg. 2010 Aug;62(1):35-40.
140. Chaudhray B, Glancy D, Dixon A. Laparoscopic surgery for recurrent ileocolic
Crohn’s disease is as safe and effective as primary resection. Colorectal Dis. 2010 Nov
18. doi: 10.1111/j.1463-1318.2010.02511.x. Epub ahead of print.
141. Schwartz M, Regueiro M. Prevention and Treatment of Postoperative Crohn’s
Disease Recurrence: An Update for a New Decade. Curr Gastroenterol Rep. 2010 Nov
2. Epub ahead of print.
142. Bordeianou L, Stein SL, Ho VP, et al.: Immediate versus tailored prophylaxis
to prevent symptomatic recurrences after surgery for ileocecal Crohn’s disease?
Surgery. 2010 Apr 29. Epub ahead of print.
143. Malireddy K, Larson DW, Sandborn WJ, et al.: Recurrence and impact of
postoperative prophylaxis in laparoscopically treated primary ileocolic Crohn disease.
Arch Surg. 2010 Jan;145(1):42-7.
144. Swoger JM, Regueiro M. Postoperative Crohn’s disease: how can we prevent
it? Expert Rev Clin Immunol. 2010 Jul;6(4):501-4.
145. Brouquet A, Blanc B, Bretagnol F, et al.: Surgery for intestinal Crohn’s disease
recurrence. Surgery. 2010 Nov;148(5):936-46. Epub 2010 Apr 2.
146. Zerbib P, Koriche D, Truant S, et al.: Pre-operative management is associated
with low rate of post-operative morbidity in penetrating Crohn’s disease. Aliment
Pharmacol Ther. 2010 Aug;32(3):459-65. Epub 2010 May 22.
147. Sciaudone G, Di Stazio C, Limongelli P, et al.: Treatment of complex perianal
fistulas in Crohn disease: infliximab, surgery or combined approach. Can J Surg.
2010. Oct; Vol. 53(5):299-304.
148. Roumeguère P, Bouchard D, Pigot F, et al.: Combined approach with
infliximab, surgery, and methotrexate in severe fistulizing anoperineal crohn’s disease:
Results from a prospective study. Inflamm Bowel Dis. 2010 Jul 8. Epub ahead of
print.
149. Chung W, Ko D, Sun C, et al.: Outcomes of anal fistula surgery in patients with
inflammatory bowel disease. Am J Surg. 2010 May;199(5):609-13.
150. Pinto RA, Peterson TV, Shawki S, et al.: Are there predictors of outcome
following rectovaginal fistula repair? Dis Colon Rectum. 2010 Sep;53(9):1240-7.
151. Randall J, Singh B, Warren BF, et al.: Delayed surgery for acute severe colitis
is associated with increased risk of postoperative complications. Br J Surg. 2010
Mar;97(3):404-9.
152. Cima RR. Timing and indications for colectomy in chronic ulcerative colitis:
surgical consideration. Dig Dis. 2010;28(3):501-7. Epub 2010 Sep 30.
153. Coquet-Reinier B, Berdah SV, Grimaud JC, et al.: Preoperative infliximab
treatment and postoperative complications after laparoscopic restorative
proctocolectomy with ileal pouch-anal anastomosis: a case-matched study. Surg
Endosc. 2010 Aug;24(8):1866-71. Epub 2010 Jan 28.
154. Yang Z, Wu Q, Wu K, et al.: Meta-analysis: pre-operative infliximab treatment
and short-term post-operative complications in patients with ulcerative colitis. Aliment
Pharmacol Ther. 2010 Feb 15;31(4):486-92. Epub 2009 Nov 19.
155. Ikeuchi H, Uchino M, Matsuoka H, et al.: Surgery for ulcerative colitis in 1,000
patients. Int J Colorectal Dis. 2010 Aug;25(8):959-65. Epub 2010 Mar 9.
156. Szepes Z, Molnár T, Farkas K, et al.: Better quality of life after surgery
treatment in patients with colitis ulcerosa: what is the price. Orv Hetil. 2010 Aug
1;151(31):1264-9.
157. Somashekar U, Gupta S, Soin A, et al.: Functional outcome and quality of life
following restorative proctocolectomy for ulcerative colitis in Indians. Int J Colorectal
Dis. 2010 Aug;25(8):967-73. Epub 2010 Jun 8.
158. Wibmer AG, Kroesen AJ, Gröne J, et al.: Predictors of permanent ileostomy
after restorative proctocolectomy.Br J Surg. 2010 Oct;97(10):1561-6.
159. Burns EM, Bottle A, Aylin P, et al.: Volume analysis of outcome following
restorative proctocolectomy. Br J Surg. 2010 Nov 11. Epub ahead of print.
160. Brisinda G, Vanella S, Valenza V, et al.: Surgical Prophylaxis of Pouchitis in
Ulcerative Colitis. Dig Dis Sci. 2010 Dec 3. Epub ahead of print.
161. Fajardo AD, Dharmarajan S, George V, et al.: Laparoscopic versus open 2-
stage ileal pouch: laparoscopic approach allows for faster restoration of intestinal
continuity. J Am Coll Surg. 2010 Sep;211(3):377-83.
162. Wu XJ, He XS, Zhou XY, et al.: The role of laparoscopic surgery for ulcerative
colitis: systematic review with meta-analysis. Int J Colorectal Dis. 2010
Aug;25(8):949-57. Epub 2010 Feb 17.
163. Marin, Ho, Barnhart, et al.: Percutaneous Abscess Drainage
in Patients With Perforated Acute Appendicitis: Effectiveness, Safety, and Prediction
of Outcome AJR 2010; 194:422–429
164. Toorenvliet, Wiersma, Bakker, et al.: Routine Ultrasound and Limited
Computed Tomography for the Diagnosis of Acute Appendicitis World J Surg (2010)
34 :2278–2285.
165. Kristen, DeStigter, Keating. Imaging Update: Acute Colonic Diverticulitis.
Clin Colon Rectal Surg 2009; 22:147–155.
166. Quirke P, Risio M, Lambert R et al.: Quality assurance in pathology in
colorectal cancer screening and diagnosis – European recommendations. Virchows
Arch 2010 Nov 9. [Epub ahead of print]
167. Vieth M, Quirke P, Lambert R et al.: Annex to Quirke et al. Quality assurance
in pathology in colorectal cancer screening and diagnosis: annotations of colorectal
cancer. Virchows Arch 2010 Nov 9. [Epub ahead of print]
168. Pai RK, Hart J, Noffsinger A. Sessile serrated adenomas strongly predispose to
synchronous serrated polyps in non-syndromic patients. Histopathology 2010;56:581-
588.
169. Tescher, Macrae, Speer et al.: Surveillance of FAP: a prospective blinded
comparison of capsule endoscopy and other GI imaging to detect small bowel polyps.
Hereditary Cancer in Clinical Practice 2010, 8: 3
170. Gupta, Postgate, Burling et al.: A Prospective Study of MR Enterography
Versus Capsule Endoscopy for the Surveillance of Adult Patients With Peutz-Jeghers
Syndrome. AJR 2010; 195:108–116.
171. Zavoral M, Suchanek S, Zavada F, et al.: Colorectal cancer screening in
Europe. World J Gastroenterol 2009;15:5907-15.
172. Long MD, Martin CF, Galanko JA, et al.: Hormone replacement therapy, oral
contraceptive use, and distal large bowel cancer: a population-based case-control
study. Am J Gastroenterol. 2010;105:1843-1850.
173. Söderlund S, Granath F, Broström O, et al.: Inflammatory bowel disease
confers a lower risk of colorectal cancer to females than to males. Gastroenterology
2010;138:1697-1703.
174. Gellad ZF, Weiss DG, Ahnen DJ et al.: Colonoscopy withdrawal time and risk
of neoplasia at 5 years. Am J Gastroenterol 2010;105:1746–1752
175. Kaminski MF, Regula J, Kraszewska E, et al.: Quality indicators for
colonoscopy and the risk of interval cancer. NEJM 2010;362:1795-1803.
176. Hoffmeister M, Schmitz S, Karmrodt E, et al.: Male sex and smoking have a
larger impact ont he prevalence of colorectal neoplasia than family history of
colorectal cancer. Clin Gastroenterol Hepatol 2010;8:870-876.
177. Senore C, Armaroli P, Silvani M, et al.: Comparing different screening
strategies for colorectal cancer screening in Italy: predictors of patients’ participation.
Am J Gastroenterol 2010;105:188-198.
178. Sawhney MS, McDougall H, Nelson DB, et al.: Fecal occult blood test in
patients on low-dose aspirin, warfarin, clopidogrel, or non-steroidal anti-inflammatory
drugs. Dig Dis Sci 2010;55:1637-1642.
179. Kershenbaum A, Lavi I, Rennert G, et al.: Fecal occult blood test performance
indicators in warfarin-treated patients. Dis Colon Rectum 2010;53:224-229.
180. Brenner H, Tao S, Haug U. Low-dose aspirin use and performance of
immunochemical fecal occult blood tests. JAMA 2010;304:2513-2520.
181. Lynch PM, Ayers GD, Hawk E, et al.: The safety and efficacy of celecoxib in
children with familial adenomatous polyposis. Am J Gastroenterol 2010;105:1437-
1443.
182. Caroll C, Cooper K, Papaioannou D, et al.: Meta-analysis: folic acid in the
chemoprevention of colorectal adenomas and colorectal cancer. Aliment Pharmacol
Ther 2010; 31:708–718.
183. C. Stock, H. Brenner. Utilization of lower gastrointestinal endoscopy and
FOBT in 11 Europen countries: evidence from the Survey of Health, Aging and
Retirement in Europe (SHARE). Endoscopy 2010; 42:546-556
184. Joo MK, Park JJ, Lee WW, et al.: Differences in the prevalence of colorectal
polyps in patients undergoing endoscopic removal of gastric adenoma or early gastric
cancer and in healthy individuals Endoscopy 2010; 42:114-20.
185. Gallegos-Orozco JF, Gurudu SR. Complex colon polypectomy. Gastroenterol
Hepatol. 2010;6:375-82.
186. Fyock CJ, Draganov PV. Colonoscopic polypectomy and associated
techniques. World J Gastroenterol. 2010; 7:3630-7.
187. Geraci G, Pisello F, Arnone E, et al.: Endoscopic Resection of a Large Colonic
Lipoma: Case Report and Review of Literature. Case Rep Gastroenterol. 2010;4:6-11.
188. Moss A, Bourke M.J, Sharma S, et al.: Lesion isolation by circumferential
submucosal incision prior to endoscopic mucosal resection (CSI-EMR) substantially
improves en bloc resection rates for 40-mm colonic lesions. Endoscopy 2010;42:400-
404
189. Akahoshi K, Okamoto R, Nakamura K, et al.: Endoscopic submucosal
dissection of early colorectal tumors using a grasping-type scissors forceps: a
preliminary clinical study. Endoscopy 2010;42: 419-422
190. Lohsiriwat V. Colonoscopic perforation: incidence, risk factors, management
and outcome. World J Gastroenterol. 2010;16:425-30. Review.
191. Rabeneck L, Saskin R, Paszat LF. Onset and clinical course of bleeding and
perforation after outpatient colonoscopy: a population-based study. Gastrointest
Endosc. 2010 Dec 30.
192. Tong LL, Gao P, Wang ZN, et al.: Is pT2 subclassification feasible to predict
patient outcome in colorectal cancer? Ann Surg Oncol 2010 Nov 24. [Epub ahead of
print]
193. Polheimer MJ, Kornprat P, Pollheimer VS, et al.: Clinical significance of pT
sub-classification in surgical pathology of colorectal cancer. Int J Colorectal Dis
2010;25:187-196.
194. Lu FI, van Niekerk DW, Owen D, et al.: Longitudinal outcome study of sessile
serrated adenomas of the colorectum: An increased risk for subsequent right-sided
colorectal carcinomas. Am J Surg Pathol 2010;34:927-934.
195. Hyung Y, Jeong SY, Lim SB, et al.: Influence of preoperative
chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer. Ann Surg
2010;252:336-340.
196. Latkauskas T, Lizdenis P, Janciauskiené R, et al.: Lymph node retrieval after
resection of rectal cancer following preoperative chemoradiotherapy. Medicina
(Kaunas) 2010;46:299-304.
197. Cserni G, Bori J, Sejben I. Limited lymph-node recovery based on lymph-node
localisation is sufficient for accurate staging. J Clin Pathol 2010 Oct 14. [Epub ahead
of print]
198. Roxbourgh CSD, McMillan DC, Anderson JH, et al.: Elastica staining for
venous invasion results in superior prediction of cancer-specific survival in colorectal
cancer. Ann Sug 2010;252:989997.
199. Sejben I, Bori R, Cserni G. Venous invasion demonstrated by orcein staining of
colorectal carcinoma specimens is associated with the development of distant
metastasis. J clin Pathol 2010;63:575-578.
200. Huh JW, Kim HR, Kim YJ. Lymphovascular or perineural invasion may predict
lymph node metastasis in patients with T1 and T2 colorectal cancer. J Gastrointest
Surg 2010;14:1074-1080.
201. Wasif N, Faries MB, Saha S, et al.: Predictors of occult nodal metastasis in
colon cancer: Results from a prospective multicentric trial. Surgery 2010;147:352-
357.
202. West NP, Dattani M, McShane P, et al.: The proportion of tumour cells is an
independent predictor for survival in colorectal patients. Br J Cancer 2010;102:1519-
1523.
203. West NP, Anderin C, Smith KJ, et al.: Multicentric experience with
extralevator abdominoperineal excision for low rectal cancer. Br J Surg 2010;97:588-
599.
204. West NP, Hohenberger W, Weber K, et al.: Complete mesocolic excision with
central vascular ligation procedures an oncologically superior specimen compared
with standard surgery for carcinoma of the colon. J Clin Oncol 2010;28:272-278.
205. Wittekind C, Compton C, Quirke P, et al.: A uniform residual tumor R
classification. Integration of the R classification and the circumferencial margin.
Cancer 2009; 115:3483-8.
206. Bujko K, Kolodziejczyk M, Nasierowska-Guttmejer A, et al.: Tumor regression
grading in patients with residual rectal cancer after preoperative chemoradiation.
Radiother Oncol 2010 ;95:298-302.
207. Puppa G, Sonzogni A, Colombari R, et al.: TNM Staging system of colorectal
carcinoma. A critical appraisal of challenging issues. Arch Pathol Lab Med 2010
134:837-852.
208. Quirke P, Cuvelier C, Ensari A, et al.: Evidence-based medicine: the time has
come to set standards for staging. J Pathol 2010;221:357-360.
209. Roxbourgh CSD, McMillan DC, Anderson JH, et al.: Elastica staining for
venous invasion results in superior prediction of cancer-specific survival in colorectal
cancer. Ann Sug 2010;252:989997.
210. Rubio CA, Lindh C, Törnblom H, et al.: Protruding and non-protruding colon
carcinomas originating in gut-associated lymphoid tissue. Antican Res 2010;30:3019-
3022.
211. Bogner B. A colorectalis carcinomák multidiszciplináris szemléletű patológiai
vizsgálata – A biopsziás mintától a K-RAS-mutáció-analízisig. LAM 2010;20:599-
605.
212. Friedman, Downing, Chino, et al.: Feasibility of Remote CT Colonography at
Two Rural Native American Medical Centers. AJR 2010; 195:1110–1117
213. Moawad, Maydonovitch, Cullen, et al.: CT Colonography May Improve
Colorectal Cancer Screening Compliance. AJR 2010; 195:1118–1123
214. Kim, Yee. Bridging the Gap: Using CT Colonography to Improve Colorectal
Cancer Screening Compliance. AJR 2010; 195:1107–1109
215. Fletcher, Chen, Herman, et al.: Can Radiologist Training and Testing Ensure
High Performance in CT Colonography? Lessons From the National CT
Colonography Trial. AJR 2010; 195:117–125
216. Shyn, Madan, Wu, et al.: PET/CT Pattern Analysis for Surgical Staple Line
Recurrence in Patients With Colorectal Cancer. AJR 2010; 194: 14–421
217. Figueiras, Goh, Padhani, et al.: The Role of Functional Imaging in Colorectal
Cancer. AJR 2010; 195: 54–66
218. Metser, You, McSweeney, et al.: Assessment of Tumor Recurrence in Patients
With Colorectal Cancer and Elevated Carcinoembryonic Antigen Level: FDG PET/CT
Versus Contrast-Enhanced 64-MDCT of the Chest and Abdomen. AJR 2010;
194:766–771
219. Kamaoui, De-Luca, Ficarelli, et al.: Value of CT Enteroclysis in Suspected
Small-Bowel Carcinoid Tumors. AJR 2010; 194:629–633
220. Quirke P, Steele R, Monson J, et al: MRC CR07/NCIC-CTG CO16 Trial
Investigators; NCRI Colorectal Cancer Study Group. Effect of the plane of surgery
achieved on local recurrence in patients with operable rectal cancer: a prospective
study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial.
Lancet. 2009 Mar 7;373(9666):821-828.
221. Leonard D, Penninckx F, Fieuws S, et al.: PROCARE, a multidisciplinary
Belgian Project on Cancer of the Rectum. Factors predicting the quality of total
mesorectal excision for rectal cancer. Ann Surg. 2010 Dec;252(6):982-988.
222. Miscusi G, di Gioia CR, Patrizi G, et al.: Anatomical lymph node mapping in
normal mesorectal adipose tissue. Dis Colon Rectum. 2010 Dec;53(12):1640-1644.
223. Stillwell AP, Ho YH, Veitch C. Systematic Review of Prognostic Factors
Related to Overall Survival in Patients with Stage IV Colorectal Cancer and
Unresectable Metastases. World J Surg. 2010 Dec 23.
224. Ho TW, Mack LA, Temple WJ. Operative salvage for retroperitoneal nodal
recurrence in colorectal cancer: A Systematic Review. Ann Surg Oncol. 2010 Sep 18.
[Epub ahead of print]
225. Matsuda K, Hotta T, Takifuji K, et al.: Clinical impact of a macroscopically
complete resection of colorectal cancer with peritoneal carcinomatosis. Surgery. 2010
Dec 20. [Epub ahead of print]
226. Cavaliere F, De Simone M, Virzì S, et al.: Prognostic factors and oncologic
outcome in 146 patients with colorectal peritoneal carcinomatosis treated with
cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy:
Italian multicenter study S.I.T.I.L.O. Eur J Surg Oncol. 2010 Nov 17. [Epub ahead of
print]
227. Glehen O, Gilly FN, Boutitie F, et al.: Toward curative treatment of peritoneal
carcinomatosis from nonovarian origin by cytoreductive surgery combined with
perioperative intraperitoneal chemotherapy: A multi-institutional study of 1290
patients. Cancer. 2010 Dec 15;116(24):5608-5618.
228. Hendren S, Birkmeyer JD, Yin H, et al.: Surgical Complications Are
Associated With Omission of Chemotherapy for Stage III Colorectal Cancer. Dis
Colon Rectum. 2010 Dec;53(12):1587-1593.
229. de Campos-Lobato LF, Geisler DP, da Luz Moreira A, et al.: Neoadjuvant
Therapy for Rectal Cancer: The Impact of Longer Interval Between Chemoradiation
and Surgery. J Gastrointest Surg. 2010 Dec 8. [Epub ahead of print]
230. Yeo SG, Kim DY, Kim TH, et al.: Pathologic complete response of primary
tumor following preoperative chemoradiotherapy for locally advanced rectal cancer:
long-term outcomes and prognostic significance of pathologic Nodal Status (KROG
09-01). Ann Surg. 2010 Dec;252(6):998-1004.
231. Kang J, Hur H, Min BS, et al.: Prognostic Impact of Inferior Mesenteric Artery
Lymph Node Metastasis in Colorectal Cancer. Ann Surg Oncol. 2010 Sep 21. [Epub
ahead of print]
232. Moug SJ, McColl G, Lloyd SM, et al.: Comparison of positive lymph node
ratio with an inflammation-based prognostic score in colorectal cancer. Br J Surg.
2011 Feb;98(2):282-6. Epub 2010 Oct 25.
233. Lacy AM. The Long-term Results of a Randomized Clinical Trial of
Laparoscopy-assisted Versus Open Surgery for Colon Cancer, Annals of Surgery 248:
1-7, 2008
234. Huang MJ, Liang JL, Wang H, et al.: Laparoscopic-assisted versus open
surgery for rectal cancer: a meta-analysis of randomized controlled trials on oncologic
adequacy of resection and long-term oncologic outcomes. Int J Colorectal Dis. 2010
Dec 21.
235. Kang SB, Park JW, Jeong SY, et al.: Open versus laparoscopic surgery for mid
or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term
outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010
Jul;11(7):637-645.
236. Verheijen PM, Stevenson AR, Lumley JW, et al.: Laparoscopic resection of
advanced colorectal cancer. Br J Surg. 2010 Nov 25.
237. Park JS, Choi GS, Lim KH, et al.: Clinical outcome of laparoscopic right
hemicolectomy with transvaginal resection, anastomosis, and retrieval of specimen.
Dis Colon Rectum. 2010 Nov;53(11):1473-1479.
238. Keshava A, Mackenzie S, Al-Kubati W. Single-port laparoscopic right colonic
resection. ANZ J Surg. 2010 Jan;80(1-2):30-2.
239. Wong MT, Ng KH, Ho KS, et al.: Single-incision laparoscopic surgery for right
hemicolectomy: our initial experience with 10 cases. Tech Coloproctol. 2010
Sep;14(3):225-8. Epub 2010 Jun 30.
240. Gash KJ, Goede AC, Chambers W, et al.: Laparoendoscopic single-site surgery
is feasible in complex colorectal resections and could enable day case colectomy. Surg
Endosc. 2010 Aug 24. [Epub ahead of print]
241. Lezoche G, Guerrieri M, Baldarelli M, et al.: Transanal endoscopic
microsurgery for 135 patients with small nonadvanced low rectal cancer (iT1-iT2,
iN0): short- and long-term results. Surg Endosc. 2010 Oct 7. [Epub ahead of print]
242. Slim K, Vicaut E, Launay-Savary MV, et al.: Updated systematic review and
meta-analysis of randomized clinical trials on the role of mechanical bowel
preparation before colorectal surgery. Ann Surg. 2009 Feb;249(2):203-209.
243. Bretagnol F, Panis Y, Rullier E, et al.: French Research Group of Rectal
Cancer Surgery (GRECCAR). Rectal cancer surgery with or without bowel
preparation: The French GRECCAR III multicenter single-blinded randomized trial.
Ann Surg. 2010 Nov;252(5):863-8.
244. Marwan K, Staples MP, Thursfield V, et al.: The rate of abdominoperineal
resections for rectal cancer in the state of Victoria, Australia: a population-based
study. Dis Colon Rectum. 2010 Dec;53(12):1645-1651.
245. Archampong D, Borowski DW, Dickinson HO. Impact of surgeon volume on
outcomes of rectal cancer surgery: a systematic review and meta-analysis. Surgeon.
2010 Dec;8(6):341-52. Epub 2010 Aug 7.
246. Hwang MR, Sohn DK, Park JW, et al.: Small-dose India ink tattooing for
preoperative localization of colorectal tumor. J Laparoendosc Adv Surg Tech A. 2010
Nov;20(9):731-4. Epub 2010 Sep 29.
247. Conaghan P, Maxwell-Armstrong C, Garrioch M, et al.: Leaving a mark: the
frequency and accuracy of tattooing prior to laparoscopic colorectal surgery.
Colorectal Dis. 2010 Sep 22. doi: 10.1111/j.1463-1318.2010.02423.x. [Epub ahead of
print]
248. Iversen LH, Kratmann M, Bøje M, et al.: Self-expanding metallic stents as
bridge to surgery in obstructing colorectal cancer. Br J Surg. 2011 Feb;98(2):275-281.
249. Douillard JY, Siena S, Cassidy J, … Bodoky Gy, et al.: Randomized, Phase III Trial of
Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus
FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic
Colorectal Cancer: The PRIME Study. JCO Nov 1, 2010:4697–4705;
250. Peeters M, Price TJ, Cervantes A, et al.: Randomized Phase III Study of Panitumumab
With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As
Second-Line Treatment in Patients With Metastatic Colorectal Cancer. JCO Nov 1, 2010:4706–
4713;
251. Axel Grothey. EGFR Antibodies in Colorectal Cancer: Where Do They Belong?
JCO Nov 1, 2010:4668-4670;
252. Van Cutsem E, Lambrechts D, Prenen H, et al.: Lessons From the Adjuvant
Bevacizumab Trial on Colon Cancer: What Next? JCO Jan 1, 2011:1–4;
253. Laurent-Puig P, Cayre A, Manceau G, et al.: Analysis of PTEN, BRAF, and
EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS
Metastatic Colon Cancer. JCO Dec 2009: 5924–5930.
254. Richman SD, Seymour MT, Chambers P, et al.: KRAS and BRAF Mutations in
Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not
Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS
Trial. JCO Dec 2009: 5931–5937.
255. Kopetz S, Hoff PM, Morris JS, et al.: Phase II Trial of Infusional Fluorouracil,
Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and
Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance. JCO Jan
2010: 453–459.
256. Roth AD, Tejpar S, Delorenzi M,… Bodoky Gy, et al.: Prognostic Role of
KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the
Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial. JCO Jan
2010: 466–474.
257. Bertagnolli M. The Forest and the Trees: Pathways and Proteins As Colorectal
Cancer Biomarkers. JCO Dec 2009: 5866–5867
258. Chibaudel B, Maindrault-Goebel F, Lledo F, et al.: Can Chemotherapy Be
Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR
OPTIMOX2 Study. JCO Dec 2009: 5727–5733.
259. Howard S. Hochster. Stop and Go: Yes or No? JCO Dec 2009: 5677–5679.
260. Sargent DJ, Marsoni S, Monges G, et al.: Defective Mismatch Repair As a
Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in
Colon Cancer. JCO Jul 2010: 3219–3226.
261. Ng K, Schrag D. Microsatellite Instability and Adjuvant Fluorouracil
Chemotherapy: A Mismatch? JCO Jul 2010: 3207–3210
262. O’Connell MJ, Lavery I, Yothers G, et al.: Relationship Between Tumor Gene
Expression and Recurrence in Four Independent Studies of Patients With Stage II/III
Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil
Plus Leucovorin. JCO Sep 1, 2010:3937–3944;
263. Tabernero J. Multigene Assays to Improve Assessment of Recurrence Risk
and Benefit From Chemotherapy in Early-Stage Colon Cancer: Has the Time Finally
Arrived, or Are We Still Stage Locked? JCO Sep 1, 2010:3904–3907;
264. Allegra CJ,Yothers G, O’Connell MJ, et al.: Phase III Trial Assessing
Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol
C-08. JCO Jan 1, 2011:11–16;
265. Sidhu R, Brunt LK, Morlex SR. Undisclosed use of nonsteroidal antiinflammatory drugs may underlie small-bowel injury observed by capsule endoscopy.
Clin Gastroenterol Hepatol 2010;8:992-996.
266. Strate LL, Naumann CR. The role of colonoscopy and radiological procedures
in the management of acute lower intestinal bleeding. Clin Gastroenterol Hepatol
2010;8:333-343.
267. Laine L, Shah A. Randomized trial of urgent vs. elective colonoscopy in
patients hospitalized with lower GI bleeding. Am J Gastroenterol 2010;105:2636–
2641.
268. Olafsdottir LB, Gudjonsson H, Jonsdottir HH, et al.: Stability of the irritable
bowel syndrome and subgroups as measured by three diagnostid criteria – a 10-year
follow up study. Aliment Ptahmacol Ther 2011;32:670-680.
